Premenstrual Syndrome/Premenstrual Dysphoric Disorder — CPB 0512 | AETNA Coverage Update

Aetna modified CPB 0512 covering PMS and PMDD diagnosis and treatment, effective September 26, 2025. Here's what billing teams need to know about covered procedures, excluded services, and the codes that matter.

Aetna, a CVS Health company, updated its coverage policy for premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) under CPB 0512 in the Aetna system. The update affects a wide range of services — from psychiatric evaluations (CPT 90791, 90792) and thyroid labs (CPT 84436, 84439, 84443) to surgical interventions including laparoscopic oophorectomy (CPT 58661) and open hysterectomy codes across the 58150–58260 range. If your practice treats patients with PMS or PMDD and bills Aetna, this policy governs what gets paid and what gets denied.

Quick-Reference Table

Aetna PMS and PMDD Coverage Criteria and Medical Necessity Requirements 2025

The core of this Aetna PMS/PMDD coverage policy is that services are covered — but only when selection criteria are met. That phrase does real work here. Aetna does not cover PMS or PMDD treatment on diagnosis alone. The clinical record has to support medical necessity at the time of service.

What counts as medical necessity under CPB 0512? The policy frames it as services and procedures medically necessary for the diagnosis and treatment of PMS and PMDD. That means the documented symptom pattern, severity, and treatment history all factor into whether a claim holds up. Billing psychiatric evaluation codes like CPT 90791 or 90792 without documented diagnostic rationale is a direct path to claim denial.

The covered code set is broad. Aetna covers thyroid function testing — CPT 84436 (total thyroxine), 84439 (free thyroxine), and 84443 (TSH) — presumably to rule out thyroid dysfunction as an underlying cause. Psychological testing under CPT 96130, 96131, 96136, 96137, 96138, 96139, and 96146 is also covered when criteria are met. These codes cover a wide range of evaluation and testing services, from physician-administered psychological evaluations to technician-scored assessments.

Prior authorization requirements aren't explicitly detailed in the public-facing CPB 0512 summary, but surgical procedures in this policy — particularly laparoscopic removal of adnexal structures (CPT 58661) and oophorectomy (CPT 58940) — carry high prior auth risk. Don't assume surgical cases will clear without it. Confirm prior authorization requirements on a plan-by-plan basis before scheduling.

Reimbursement for these services flows only when the selection criteria are documented. That's not a technicality — it's the hinge the entire policy turns on.

Aetna PMS and PMDD Exclusions and Non-Covered Indications

This is where CPB 0512 gets complicated for billing teams. The policy lists several procedures under a group labeled alongside vestibular stimulation, plasma leptin measurement, and serum-related testing — and that group is categorized separately from covered services. The open hysterectomy codes (CPT 58150 through 58210 and 58260) fall into this grouping.

The real issue here is the grouping label. It references vestibular stimulation and plasma leptin measurement in the same breath as open hysterectomy codes. That suggests Aetna is flagging these procedures as not covered, experimental, or investigational in the context of PMS/PMDD treatment — even though hysterectomy is an established, if aggressive, treatment option for severe PMDD.

If your practice performs hysterectomies for PMDD and bills Aetna, this is a high-exposure situation. Open hysterectomy codes in the 58150–58260 range appear in a non-covered or restricted grouping under this policy. The laparoscopic hysterectomy codes (CPT 58570, 58571, 58572, 58573) are listed as "other CPT codes related to the CPB" — which means their coverage status is ambiguous, not confirmed.

Talk to your compliance officer before billing open hysterectomy codes against a PMDD diagnosis for Aetna members. The financial exposure on a denied surgical case is significant, and this policy does not clearly confirm coverage for those procedures.

Coverage Indications at a Glance

Aetna PMS and PMDD Billing Guidelines and Action Items 2025

The effective date is September 26, 2025. If you're billing Aetna for PMS or PMDD services and haven't reviewed your charge capture against CPB 0512, do it now. Here's what to do.

CPT, HCPCS, and ICD-10 Codes for PMS and PMDD Under CPB 0512

Covered CPT Codes (When Selection Criteria Are Met)

Restricted / Non-Covered CPT Codes (Open Hysterectomy Range)

These codes appear in a grouping associated with non-covered services including vestibular stimulation and plasma leptin measurement. Do not bill these against a PMS/PMDD diagnosis for Aetna members without a confirmed coverage determination.

The policy data includes additional open hysterectomy codes in the 58150–58260 range. All fall under the same restricted grouping. Verify each code with Aetna before billing.

Key ICD-10-CM Diagnosis Codes

The policy data references two ICD-10-CM codes but does not include descriptions in the provided data extract. Confirm the exact codes and descriptions in the full CPB 0512 document at the Aetna policy source. Use these codes on claims for PMS and PMDD diagnoses — missing or mismatched ICD-10 codes are a leading cause of claim denial under this policy.